Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Corrigendum to: Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis.
2017
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
.
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
Plasma Interleukin-33 level in relapsing-remitting multiple sclerosis. Is it negatively correlated with central nervous system lesions in patients with mild disability?
July 2021, Clinical neurology and neurosurgery,
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
Elevated interleukin 2 levels in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
April 1992, Annals of the New York Academy of Sciences,
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine.
June 2004, Acta neurologica Scandinavica,
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
Interleukin 17 and 10 in relapsing remitting multiple sclerosis.
July 2017, Journal of the neurological sciences,
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
Plasma thiol/disulphide homeostasis changes in patients with relapsing-remitting multiple sclerosis.
July 2021, International journal of clinical practice,
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels.
April 2015, Immunology letters,
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis.
January 2016, Current pharmaceutical design,
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
Significantly higher levels of soluble interleukin 2 in patients with relapsing-remitting multiple sclerosis compared with healthy subjects.
March 1990, Archives of neurology,
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
[Relapsing-Remitting Multiple Sclerosis].
May 2021, Brain and nerve = Shinkei kenkyu no shinpo,
Fereshteh Alsahebfosoul, and Ilnaz Rahimmanesh, and Mansour Shajarian, and Masoud Etemadifar, and Nahid Sedaghat, and Zahra Hejazi, and Shamsi Naderi
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
June 2003, Annals of neurology,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name